Abstract
Inflammation has been reported to play an important role in cardiac surgery under cardiopulmonary bypass due to systemic endotoxemia. In order to develop strategies against this injury in future we studied the combined effect of a number of inflammatory mediators in myocardial ischemia/reperfusion. Coronary sinus blood samples of ten patients undergoing coronary artery bypass graft surgery (CABG) were obtained at three time intervals (1) before onset of bypass (2) 30 min after cross clamp, and (3) 10 min after removal of cross clamp. The samples were subjected to evaluate levels of nitric oxide byproducts (nitrite and nitrate and citrulline), inflammatory cytokines (interleukin-2, interferon-γ and interleukin-6), adhesion molecules, (CD62L and CD54), ratio of cell surface markers (CD4/CD8 and TCRαβ/γδ) cell activation markers (CD69 and HLA DR) and second messengers (protein kinase C, inositol 1,4,5 triphosphate and intracellular calcium levels). Ischemia and further reperfusion resulted in significant rise in nitrite and nitrate levels (p < 0.001), interleukin-6 (p < 0.01), CD62L (p < 0.001), CD69 (p < 0.05), protein kinase C (p < 0.001) and intracellular calcium (p < 0.001). A fall in CD4/CD8 ratio was observed on reperfusion. These changes during CABG show that ischemia/reperfusion leads to a release of an array of pro-inflammatory mediators of tissue injury, which could lead to pathophysiological changes. Hence the study suggests the need of some protective therapies against these inflammatory markers.
Similar content being viewed by others
References
Hansen PR: Myocardial reperfusion injury: Experimental evidence and clinical relevance. Eur Heart J 16: 734-740, 1995
Buckberg GD, Olinger GN, Mulder DG, Moloney JV Jr: Depressed postoperative cardiac performance. Prevention by adequate myocardial protection during cardiopulmonary bypass. J Thorac Cardiovasc Surg 70: 974-988, 1975
Boyle EM, Pohlman TH, Cornejo CJ, Verrier ED: Ischemia reperfusion injury. Ann Thorac Surg 64: S24-S30, 1997
Suri RK, Ratna MS, Dhawan V, Gupta A, Gupta R, Sharma K, Thingnam SKS, Puri GD, Madhulika S, Ganguly NK: Reactive oxygen species, enzymatic and non-enzymatic antioxidants in patients undergoing open heart surgery. Ann NY Acad Sci 793: 366-370, 1996
Kurose I, Wolf R, Grisham MB, Granger DN: Modulation of ischemia/reperfusion induced microvascular dysfunction by nitric oxide. Circ Res 74: 376-382, 1994
Engelman DT, Watanabe M, Maulik N, Engelman RM, Rousou JA, Flack JE III, Deaton DW, Das DK: Critical timing of nitric oxide supplementation in cardioplegic arrest and reperfusion. Circulation 94(suppl 9): 407-411, 1996
Mori E, Haramaki N, Ikeda IH, Imaizumi T: Intra-coronary administration of L-arginine aggravates myocardial stunning through production of peroxynitrites in dogs. Cardiovasc Res 40: 113-123, 1998
Shindo T, Ikeda U, Ohkawa F, Kawahara Y, Yokayama M, Shimada K: Nitric oxide in cardiac myocytes and fibroblasts by inflammatory cytokines. Cardiovasc Res 29: 813-819, 1995
McBride WT, Amstrong MA, Crockard AD, Memurray TJ, Rea JM: Cytokine balance and immunosuppressive changes at cardiac surgery: Contrasting response between patients and isolated CPB circuits. Br J Anaesth 75: 724-733, 1995
Haught WH, Mansoor M, Rothlein R, Kishimoto TK, Mainolfi EA, Hendricks JB, Hendricks C, Menta JL: Alterations in circulating intracellular adhesion molecule-1 and L-selectin. Further evidence for chronic inflammation in ischemic heart disease. Am Heart J 132: 1-8, 1996
DePalma L, Yu M, McIntosh CL, Swain JA, Davey RJ: Changes in lymphocyte subpopulation as a result of cardiopulmonary bypass. J Thorac Cardiovasc Surg 101: 240-244, 1991
Toft P, Tonnesen E, Zulow I, Nielsen CH, Hokland M: Expression of adhesion and activation molecules on lymphocytes during open heart surgery with cardiopulmonary bypass. Scan Cardiovasc J 31: 91-95, 1997
Berridge MJ: Inositol triphosphate and calcium signaling. Nature 361: 315-325, 1993
Anderson KE, Dart AM, Woodcock EA: Inositol phosphate release and metabolism during myocardial ischemia and reperfusion in rat heart. Circ Res 76: 261-268, 1995
Boyum A: Isolation of mononuclear cells and granulocytes from human blood. Scand J Clin Lab Invest 219(suppl 97): 77-89, 1968
Green LC, Wagner DA, Glowgowski J, Skipper PL, Wishnok JS, Tannenbaum SR: Analysis of nitrate, nitrite and (15 N) nitrate in biological fluids. Anal Biochem 126: 131-138, 1982
Rothnagel JA, Rogers GE: Citrulline in proteins from enzymatic determination of arginine residue. Meth Enzymol 107: 624-631, 1984
Mosman TR, Coffman RE: TH1 and TH2 cells: Different kinds of lymphokine secretion lead to different functional properties. Annu Rev Immunol 7: 145-173, 1989
McCarthy SA, Hallam TJ, Meritt JE: Activation of protein kinase C in human neutrophils attenuates agonist stimulated rise in cytosolic free calcium concentration by inhibiting bivalent influx and intracellular calcium release in addition to stimulating calcium efflux. Biochem J 264: 357-374, 1989
Oldham KG: Phosphoinositide turnover. In: E.C. Hulme (ed). Receptor Effector Coupling. A Practical Approach. Oxford University Press, 1990, pp 99-102
Wolfson M, McPhail LC, Nasrullah VN, Synderman R: Phorbolmyristate acetate mediates redistribution of protein kinase C in human neutrophils: Potential role in the action of the respiratory burst enzyme. J Immunol 135: 2057-2062, 1985
Anggard E: Nitric oxide, mediator, murderer, and medicine. Lancet 343: 1199-1206, 1994
Hogg H, Darley-Usmer VM, Wilson MT, Moncada S: Production of hydroxyl radicals from the simultaneous generation of superoxide and nitric oxide. Biochem J 281: 419-424, 1991
Morita K, Sherman MP, Buckberg GD, Ihnken K, Matheis G, Young HH, Ignarro LJ: Studies of hypoxemic/reoxygenetion injury: without aortic cross clamping. Role of the L-arginine-nitric oxide paradox. J Thorac Cardiovasc Surg 110: 1200-1211, 1995
Xu Q, Oberhuber G, Gruschwitz M, Wick G: Immunology of atherosclerosis: Cellular composition and major histocompatibility complex class 11 antigen expression in aortic intima, fatty streaks and atherosclerotic plaques in young aged human specimens. Clin Immunol Immunopathol 56: 344-359, 1990
Prete GD, De Carli M, Almerigogna F, Giudizi MG, Biagiotti R, Romagnani S: Human IL-10 is produced by both type 1 and type 11 helper T cell clones And inhibits their antigen specific proliferation and cytokine function. J Immunol 150: 353-360, 1993
Sawa Y, Ichikawa H, Kagisaki K, Ohata T, Matsuda H: Interleukin-6 derived from hypoxic myocytes promotes neutrophil-mediated reperfusion injury in myocardium. Thorac Cardiovasc Surg 116: 511-517, 1998
Hennein HA, Ebba H, Rodriguez JL, Merrick SH, Keith FM, Bronstein MH, Leung JM, Mangano DT, Greenfield LJ, Rankin JS: Relationship of the pro-inflammatory cytokines to myocardial ischemia and dysfunction after uncomplicated coronary revascularization. J Thorac Cardiovasc Surg 108: 626-635, 1994
Gascon P, Zoumbos NC, Young NS: Immunologic abnormalities in patients receiving multiple blood transfusions. Ann Int Med 100: 173-177, 1984
Graves J, Lucas S, Cantrell D: Regulation of protein kinase C in lymphocytes. In: R.C. Rees (ed). The Biology and Clinical Applications of IL-2. Oxford University Press, 1991, pp 82-89.
Galinanes M, Watson C, Trivedi V, Chambers DJ, Young CD, Venn GE: Differential patterns of neutrophil adhesion molecules during cardiopulmonary bypass in humans. Circulation 94(suppl): 364-369, 1996
Le Deist F, Menasch P, Bel H, Lariviere J, Piwnica H, Bloch G: Patterns of changes in neutrophil adhesion molecules during cardiopulmonary bypass. A clinical study. Eur J Cardiol Thorac Surg 10: 279-283, 1996
Dreyer WT, Micheal LH, Millman EE, Berens KL: Neutrophil activation and adhesion molecule expression in canine model of open-heart surgery with cardiopulmonary bypass. Cardiovasc Res 29: 775-781, 1995
Boldt J, Kumle B, Papsdorf M, Hempelmann G: Are circulating adhesion molecules specifically changed in cardiac surgical patients? Ann Thorac Surg 65: 608-614, 1998
Galea JL, Finn AR: Circulating adhesion molecules in cardiac surgical patients. Ann Thorac Surg 66: 1466-1472, 1998
Nishizuka Y: Studies and perspectives of protein kinase C. Science 233: 305-312, 1986
Talmor D, Applebaum A, Rudich A, Shapira Y, Tirosh A: Activation of mitogen activated protein kinases in human during cardiopulmonary bypass. Circ Res 86: 1004-1007, 2000
Rana SR, Hokin LE: Role of phosphoinositides in transmembrane signaling. Phys Rev 70: 115-163, 1990
Parker I, Ivorra I: Inhibition by Ca2+ of inositol triphosphate mediated Ca2+ liberation: A possible mechanism for oscillatory release of Ca2+. Proc Natl Acad Sci USA 87: 260-264, 1990
Testi R, Ambrosio DD, Maria RD, Santoni A: The CD69 receptor: A multipurpose all surface trigger for hematopoietic cells. Immunol Today 15: 479-483, 1994
Testi R, Cifone MG, Santoni A: Role of CD69 in NO production by human monocytes. Res Immunol 146: 682-683, 1995
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Sharma, M., Ganguly, N.K., Chaturvedi, G. et al. Release of pro-inflammatory mediators during myocardial ischemia/reperfusion in coronary artery bypass graft surgery. Mol Cell Biochem 247, 23–30 (2003). https://doi.org/10.1023/A:1024155925106
Issue Date:
DOI: https://doi.org/10.1023/A:1024155925106